WhichRecall
Class IIReported 2025-08-06

Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25

Recalled by Hikma Pharmaceuticals USA Inc.

Reason for Recall

Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds

Advertisement
Recall Number
D-0551-2025
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-07-22
Reported
2025-08-06
Distribution
Distributed Nationwide in the USA
Code Info
Lot # K24118, exp. date 10/31/2026
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement